REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,785,000 | +455.9% | 85,000 | +347.4% | 0.08% | +680.0% |
| Q4 2021 | $501,000 | -41.0% | 19,000 | +216.7% | 0.01% | -66.7% |
| Q2 2021 | $849,000 | -14.8% | 6,000 | -40.0% | 0.03% | +20.0% |
| Q1 2021 | $997,000 | +582.9% | 10,000 | +566.7% | 0.02% | +400.0% |
| Q3 2020 | $146,000 | -92.5% | 1,500 | -88.0% | 0.01% | -96.3% |
| Q2 2020 | $1,950,000 | +138.4% | 12,500 | +212.5% | 0.14% | +164.7% |
| Q4 2019 | $818,000 | +581.7% | 4,000 | +166.7% | 0.05% | +363.6% |
| Q3 2019 | $120,000 | -15.5% | 1,500 | 0.0% | 0.01% | -31.2% |
| Q2 2019 | $142,000 | +10.9% | 1,500 | 0.0% | 0.02% | +23.1% |
| Q1 2019 | $128,000 | – | 1,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |